UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Dave Ricks
since
auto-detected in 1 stories
6 months ago
Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U.S. policymakers.
page 1 of 1